Home    Back

Dyn101    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
111Congenital myopathy1

111. Congenital myopathy    [ 7 clinical trials,   13 drugs,   (DrugBank: 4 drugs),   1 drug target gene,   8 drug target pathways]
Searched query = "Congenital myopathy", "Nemaline myopathy", "Central core disease", "Minicore myopathy", "Myotubular myopathy", "Centronuclear myopathy", "Congenital fiber-type disproportion myopathy"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 7 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04033159
(ClinicalTrials.gov)		January 9, 202012/6/2019Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients = 16 Years With Centronuclear MyopathiesA Phase 1/2 Trial on the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Exploratory Efficacy of DYN101 in Patients = 16 Years of Age With Centronuclear Myopathies Caused by Mutations in DNM2 or MTM1.Centronuclear MyopathyDrug: DYN101DynacureNULLRecruiting16 YearsN/AAll18Phase 1;Phase 2Belgium;Denmark;France;Germany;Netherlands;United Kingdom